Menu
GWAS Study

Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.

Folkersen L, Fauman E, Sabater-Lleal M et al.

28369058 PubMed ID
GWAS Study Type
6033 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

FL
Folkersen L
FE
Fauman E
SM
Sabater-Lleal M
SR
Strawbridge RJ
FM
Frånberg M
SB
Sennblad B
BD
Baldassarre D
VF
Veglia F
HS
Humphries SE
RR
Rauramaa R
DF
de Faire U
SA
Smit AJ
GP
Giral P
KS
Kurl S
ME
Mannarino E
ES
Enroth S
Johansson Å
ES
Enroth SB
GS
Gustafsson S
LL
Lind L
LC
Lindgren C
MA
Morris AP
GV
Giedraitis V
SA
Silveira A
FA
Franco-Cereceda A
TE
Tremoli E
GU
Gyllensten U
IE
Ingelsson E
BS
Brunak S
EP
Eriksson P
ZD
Ziemek D
HA
Hamsten A
MA
Mälarstig A
Chapter II

Abstract

Summary of the research findings

Recent advances in highly multiplexed immunoassays have allowed systematic large-scale measurement of hundreds of plasma proteins in large cohort studies. In combination with genotyping, such studies offer the prospect to 1) identify mechanisms involved with regulation of protein expression in plasma, and 2) determine whether the plasma proteins are likely to be causally implicated in disease. We report here the results of genome-wide association (GWA) studies of 83 proteins considered relevant to cardiovascular disease (CVD), measured in 3,394 individuals with multiple CVD risk factors. We identified 79 genome-wide significant (p<5e-8) association signals, 55 of which replicated at P<0.0007 in separate validation studies (n = 2,639 individuals). Using automated text mining, manual curation, and network-based methods incorporating information on expression quantitative trait loci (eQTL), we propose plausible causal mechanisms for 25 trans-acting loci, including a potential post-translational regulation of stem cell factor by matrix metalloproteinase 9 and receptor-ligand pairs such as RANK-RANK ligand. Using public GWA study data, we further evaluate all 79 loci for their causal effect on coronary artery disease, and highlight several potentially causal associations. Overall, a majority of the plasma proteins studied showed evidence of regulation at the genetic level. Our results enable future studies of the causal architecture of human disease, which in turn should aid discovery of new drug targets.

3,394 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

6033
Total Participants
GWAS
Study Type
Yes
Replicated
2,639 individuals
Replication Participants
European
Ancestry
Finland, France, Italy, Netherlands, Sweden
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.